serine has been researched along with aflatoxin b1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghebranious, N; Knoll, BJ; Lozano, G; Sell, S; Wu, H | 1 |
| Arakawa, K; Hodkinson, J; Kew, MC; Kimbi, GC; Yu, MC | 1 |
| Ağar, G; Anar, M; Öğütçü, H; Özkan, EH; Şakıyan, İ; Sarı, N | 1 |
3 other study(ies) available for serine and aflatoxin b1
| Article | Year |
|---|---|
Characterization of a murine p53ser246 mutant equivalent to the human p53ser249 associated with hepatocellular carcinoma and aflatoxin exposure.
Topics: Aflatoxin B1; Amino Acid Sequence; Animals; Arginine; Base Sequence; Carcinoma, Hepatocellular; Codon; Creatine Kinase; Genes, p53; Hepatitis B; Humans; Liver Neoplasms; Mice; Molecular Sequence Data; Mutation; Neoplastic Stem Cells; Osteosarcoma; Promoter Regions, Genetic; Protein Conformation; Sequence Homology, Amino Acid; Serine; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |
249ser p53 mutation in the serum of black southern African patients with hepatocellular carcinoma.
Topics: Adolescent; Adult; Aflatoxin B1; Age Factors; Aged; Biomarkers, Tumor; Diet; DNA, Neoplasm; Environmental Exposure; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mutation; Population Groups; Prevalence; Serine; Sex Factors; South Africa; Tumor Suppressor Protein p53 | 2005 |
Useful agents against aflatoxin B1 - antibacterial azomethine and Mn(III) complexes involving L-Threonine, L-Serine, and L-Tyrosine.
Topics: Aflatoxin B1; Anti-Bacterial Agents; Antidotes; Azo Compounds; Bacteria; Female; Humans; Male; Manganese; Serine; Thiosemicarbazones; Threonine; Tyrosine | 2016 |